Brief: Herantis Pharma H2 loss shrinks to EUR 1.8 million
28/02/2017 07:08
Feb 28 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* H2 loss 1.8 million euros ($1.9 million) versus loss 2.5
million euros year ago
* Does not expect essential revenues in 2017
* Expects to be cash positive at end of year 2017
Source text for Eikon: ID:nGNE6q2sVz
Further company coverage: HRTIS.HE
($1 = 0.9447 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))